EUVIMED · CrossrefJournal
Journal of Scleroderma and Related Disorders
ISSN 2397-1983 · SAGE Publications
Latest articles
Phase II randomised, double-blind, placebo-controlled, dose-ranging study of nemolizumab with an extension period in adult patients with systemic sclerosis: THESSALIA study design and rationale
Primary Raynaud’s phenomenon is associated with attention deficit hyperactivity disorder: a cohort study harnessing electronic healthcare records
Benchmarking gastrointestinal involvement in systemic sclerosis: practical insights and unmet needs from a tertiary referral centre
Association between bosentan and reduced detection of precapillary pulmonary hypertension in systemic sclerosis: evidence from a EUSTAR study
VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis
Improving the patient care pathway in systemic sclerosis: insights from patients and clinicians in Italy
Pathologic differences between systemic sclerosis–associated and idiopathic pulmonary arterial hypertension
Longitudinal association between nailfold capillaroscopy and incident interstitial lung disease: A EUSTAR database analysis
Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review
Anti-fibrotic effects of thrombin inhibition in systemic sclerosis-associated interstitial lung disease: Proof of concept
International expert agreement on World Scleroderma Foundation/Heart Failure Association consensus-based definition and guidance on screening, diagnosis, and follow-up assessment of systemic sclerosis–associated primary heart involvement
A systematic literature review of Janus kinase inhibitors for the treatment of systemic sclerosis
Clinical associations of worsening physical function as measured by HAQ-DI scores in systemic sclerosis
Evaluation of the type D personality and its association with cardiovascular risk and disease-related parameters in patients with systemic sclerosis
Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease
Cardiac involvement in systemic sclerosis: A critical review of knowledge gaps and opportunities
National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients
Clinical and ultrasonographic evaluation of efficacy and safety of intralesional injection of autologous platelet-rich plasma in morphea: A comparative case series
Perception of aesthetic impairment in patients with systemic sclerosis determined using a semi-quantitative scale and its association with disease characteristics
Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment
Prevalence of and factors independently associated with digital ischemic complications in patients with systemic sclerosis
Systemic sclerosis in Asians: Are there racial differences?
Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
Scleredema with biopsy-confirmed cardiomyopathy: A case report
Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients
Epidemiology and trends in survival of systemic sclerosis in Olmsted County (1980–2018): A population-based study
Circulating Gremlin-1 is elevated in systemic sclerosis patients
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement
Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches
Update on morbidity and mortality in systemic sclerosis–related interstitial lung disease
EUVIMED